Literature DB >> 565631

Serological responses in pigs vaccinated with inactivated porcine parvovirus.

H S Joo, R H Johnson.   

Abstract

The safety and immunogenicity of inactivated porcine parvovirus (PPV) vaccines were investigated. Both beta-propiolactone and formalin successfully inactivated virus without destroying immunogenicity, which was considerably enhanced by incorporation of a gel adjuvant in the vaccine. Using the formalised-gel vaccine, initial antibody responses were demonstrated in susceptible piglets and adult pigs at 7 days after vaccination. These antibody responses persist at significant levels for at least 6 months after vaccination. Antibody levels increased up to 16 fold when revaccination was carried out. Vaccination of gilts with low level (passive) immunity resulted in antibody responses comparable to those recorded in susceptible pigs. The vaccine was safe as determined by absence of residual virus in the vaccine, absence of viraemia and excretion in vaccinted stock, and absence of effect on litters of sows vaccinated at different gestational ages. Vaccine stored at 4 degrees C for 6 months was as immunogenic as fresh vaccine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 565631     DOI: 10.1111/j.1751-0813.1977.tb07945.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  9 in total

1.  Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs.

Authors:  Esther Steiner; Carole Balmelli; Heidi Gerber; Artur Summerfield; Kenneth McCullough
Journal:  BMC Vet Res       Date:  2009-12-22       Impact factor: 2.741

2.  Experience of vaccination against porcine parvovirus in pig-breeding herds: serological status and reproductive performance.

Authors:  S Einarsson; K Larsson; B Thafvelin
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

3.  Detection of challenge virus in fetal tissues by nested PCR as a test of the potency of a porcine parvovirus vaccine.

Authors:  S Belák; E Rivera; A Ballagi-Pordány; W Hanzhong; F Widén; T Soós
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

4.  Vaccination against porcine parvovirus infection.

Authors:  K J Sørensen; J Askaa
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

5.  Dynamics of vanishing of maternally derived antibodies of Ungulate protoparvovirus 1 suggests an optimal age for gilts vaccination.

Authors:  Danielle Gava; Carine Kunzler Souza; Tiago José Mores; Laura Espíndola Argenti; André Felipe Streck; Cláudio Wageck Canal; Fernando Pandolfo Bortolozzo; Ivo Wentz
Journal:  Trop Anim Health Prod       Date:  2017-05-03       Impact factor: 1.559

6.  Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides.

Authors:  T W Molitor; H S Joo; M S Collett
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  KBSH parvovirus: comparison with porcine parvovirus.

Authors:  T W Molitor; H S Joo; M S Collett
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

8.  Molecular epidemiology of Porcine Parvovirus Type 1 (PPV1) and the reactivity of vaccine-induced antisera against historical and current PPV1 strains.

Authors:  Nick Vereecke; Lise Kirstine Kvisgaard; Guy Baele; Carine Boone; Marius Kunze; Lars Erik Larsen; Sebastiaan Theuns; Hans Nauwynck
Journal:  Virus Evol       Date:  2022-06-16

Review 9.  Vaccines produced by conventional means to control major infectious diseases of man and animals.

Authors:  J L Bittle; S Muir
Journal:  Adv Vet Sci Comp Med       Date:  1989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.